California State Teachers Retirement System (CalSTRS)’s Lexeo Therapeutics LXEO Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.32K	Sell	927 -2,668	-74%	-$14.4K	﹤0.01%	2601
2026 Q1	$20.6K	Sell	3,595 -289	-7%	-$2.05K	﹤0.01%	2431
2025 Q4	$38.6K	Buy	3,884 +2,148	+124%	+$19.6K	﹤0.01%	2334
2025 Q3	$11.5K	Buy	1,736 +1	+0.1%	+$5	﹤0.01%	2776
2025 Q2	$6.97K	Hold	1,735	–	–	﹤0.01%	2855
2025 Q1	$6.02K	Hold	1,735	–	–	﹤0.01%	2891
2024 Q4	$11.4K	Hold	1,735	–	–	﹤0.01%	2817
2024 Q3	$15.7K	Buy	1,735 +993	+134%	+$11.8K	﹤0.01%	2712
2024 Q2	$11.9K	Sell	742 -289	-28%	-$4.2K	﹤0.01%	2816
2024 Q1	$16.2K	Buy	+1,031	New	+$16.1K	﹤0.01%	2800

Other funds holding LXEO

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s LXEO Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Lexeo Therapeutics (LXEO) stake by 74% in Q2 2026, selling an estimated $14.4K and leaving 927 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

California State Teachers Retirement System (CalSTRS) first reported a position in LXEO in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.6K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

California State Teachers Retirement System (CalSTRS) held 927 shares of Lexeo Therapeutics worth $4.32K as of Q2 2026.
California State Teachers Retirement System (CalSTRS) sold 2,668 Lexeo Therapeutics shares in Q2 2026, an estimated $14.4K.
Lexeo Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2601 holding.
California State Teachers Retirement System (CalSTRS) first reported a position in Lexeo Therapeutics in Q1 2024 and has held it in 10 quarters since.
California State Teachers Retirement System (CalSTRS)'s Lexeo Therapeutics position peaked at $38.6K in Q4 2025.
141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.